Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
Abstract
Diffuse Midline Glioma (DMG) with the H3K27M mutation is a lethal childhood brain cancer, with patients rarely surviving 2 years from diagnosis.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 06, 2022
- Source ID
- 10.1093/neuonc/noac030
Entities
People
- Abed Rahman Kawakibi
- Alyssa Paul
- Amy K. Bruzek
- Andrea Franson
- Carl Koschmann
- Cassie Kline
- Chase Thomas
- Clarissa May Babila
- Dustin Walling
- Evan Cantor
- Hugh J L Garton
- Jack Wadden
- Jessica R Cummings
- Johanna Ramos
- Joshua E Allen
- Karthik Ravi
- Kyle Wierzbicki
- Marcia Leonard
- Nicholas A. Vitanza
- Patricia Robertson
- Rajen Mody
- Ramya Ravindran
- Rodrigo Cartaxo
- Rohinton S Tarapore
- Sabine Müller
- Sharon L Gardner
- Soumen Khatua
- Sriram Venneti
- Sunjong Ji
- Vishal John
- Viveka Nand Yadav
- Yazmin Odia
Organizations
- Mayo Clinic
- Michigan Medicine
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
- New York University
- United States Department of Defense
- University of California, San Francisco
- University of Pennsylvania
- University of Washington